Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunophenotypic profiling of nonsmall cell lung cancer progression using the tissue microarray approach.

Judit Papay1, Tibor Krenacs, Judit Moldvay

  • 1Department of Pathology, Semmelweis University, Budapest, Hungary.

Applied Immunohistochemistry & Molecular Morphology : AIMM
|June 1, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European analysis of patients with early-stage lung adenocarcinoma and invasive pathologic features who underwent lobectomy versus segmentectomy.

The Journal of thoracic and cardiovascular surgery·2026
Same author

European prognosis evaluation of early-stage lung adenocarcinoma patterns after lobectomy versus segmentectomy based on clinical stage settings.

JTCVS open·2026
Same author

A Subphase-Labeled Mitotic Dataset for AI-powered Cell Division Analysis.

Scientific data·2026
Same author

Sample adequacy in bronchoscopic ROSE: comparison between laboratory specialist and pathologist.

Pathology oncology research : POR·2026
Same author

Enhanced Precision of Fluorescence In Situ Hybridization (FISH) Analysis Using Neural Network-Based Nuclear Segmentation for Digital Microscopy Samples.

Sensors (Basel, Switzerland)·2026
Same author

A multimodal AI biomarker PATH-ORACLE improves prediction of recurrence in stage I lung adenocarcinoma.

medRxiv : the preprint server for health sciences·2026

This study identified biomarkers for non-small cell lung cancer (NSCLC) progression and brain metastasis. Beta-catenin was a prognostic marker for better outcomes, while other proteins indicated metastatic potential.

Area of Science:

  • Oncology
  • Immunohistochemistry
  • Molecular Pathology

Background:

  • Non-small cell lung cancer (NSCLC) poses significant therapeutic challenges, particularly regarding metastatic potential.
  • Identifying biomarkers for patient survival and tumor progression is crucial for effective treatment strategies.

Purpose of the Study:

  • To perform immunomorphologic profiling of NSCLC cases using tissue microarrays.
  • To identify clinically relevant disease groups and biomarkers associated with patient survival, tumor progression, and brain metastatic potential.

Main Methods:

  • Utilized tissue microarrays from 59 NSCLC patients, including primary tumors and brain metastases.
  • Performed immunostaining for 29 markers related to cell adhesion, growth, cell cycle, and apoptosis.
  • Applied hierarchical clustering to immunoprofiles for grouping and outcome correlation.

Related Experiment Videos

Main Results:

  • Beta-catenin expression was the sole independent prognostic marker for better patient outcome.
  • Elevated collagen XVII, CD44v6, caspase-9, cyclin D1, and cyclin D3, with reduced beta-catenin and cellular apoptosis susceptibility protein, correlated with metastatic potential.
  • Brain metastases showed increased p16, syndecan-1, p53, and caspase-3 levels.
  • Immunoprofiles clustered NSCLCs with poor outcomes, including brain metastases.

Conclusions:

  • Brain metastatic potential in NSCLC is associated with specific protein expression patterns, including elevated cell cycle regulators and apoptosis-related proteins, and down-regulated beta-catenin.
  • Unsupervised immunoprofiles can aid in selecting NSCLC patients with aggressive behavior and high metastatic risk.